Expression of PTEN,HPV16/18-E6 and Estrogen Receptor and its Clinical Significance in Uterine Cervical Adenocarcinoma

Ting YU,Hai-Tao SUN,Yi ZHANG,Xiu-Juan YANG,Da-Yong ZHAO
DOI: https://doi.org/10.3969/j.issn.1009-0002.2009.03.017
2009-01-01
Abstract:Objective: To study the expression of PTEN, human papillomavirus(HPV)16 / 18-E6 and estrogen receptor(ER) and its clinical significance in uterine cervical adenocarcinoma. Methods: The expression of PTEN, HPV16 / 18-E6 and ER was detected by immunohistochemical S-P method in 65 cases of cervinoma and the same method for the expression of HPV16 / 18-E6 and ER in 30 cases of cervical chronic inflammation. Results: In the nucleus, expression of PTEN in the carcinoma was significantly reduced versus normal epithelium (P<0.01), 96% of tumors were reduced while only 35% normal were reduced (P<0.01). The positive rates of HPV16 / 18-E6 and ER in cervical adenocarcinoma were 52.1% and 49.4%, respectively, significantly higher than that in cervical chronic inflammation(P<0.01). Conclusion: PTEN may exert tumor suppression in the nucleus level and involved in the carcinogenesis of adenocarcinoma of cervix. The over expression of HPV16 / 18-E6 may play an important role in the pathogenesis of cervical adenocarcinoma. This result indicates that some of the cervical adenocarcinoma are estrogen dependent, and the estrogen may participate in the onset and pro- gression of the tumor.
What problem does this paper attempt to address?